Methods, compositions, systems and kits relating to processing of cassava bagasse into bacterial feedstock, such as bacterial feedstock suitable for nanocellulose production, are disclosed. Cassava bagasse may be contacted with an acid catalyst or an enzymatic catalyst to produce a hydrolysate, which can be used to form a pre-fermentation medium. Incubation of the pre-fermentation medium with a first population of microorganisms yields a supernatant enriched in reducing sugars, which may be used to form a culture medium which can be used to support growth of a second population of microorganisms to form the nanocellulose.

The present invention relates to a process for microbial synthesis process having less water consumption and yielding desired product profile. More particularly, the present invention relates to an improved process of microbial synthesis using ultra fine nutrient mist in a specially designed biofilm-bioreactor under controlled conditions. The present invention also relates to an apparatus for microbial synthesis and preparation of optimized biofilm for continuous product formation.

It has been discovered that the desert endophytic bacterium SA187 SA187 can provide resistance or tolerance to abiotic stress conditions to seeds or plants. Compositions containing SA187 can be used to enhance plant development and yield under environmental stress conditions.

The present disclosure provides an Alcaligenes faecalis strain capable of degrading ethylene oxide and uses thereof. The deposit number of the strain is CGMCC No. 18435. This strain can be used in pollution treatment, for example, to treat industrial sewage or wastewater containing ethylene oxide, which greatly improves the decontamination ability of ethylene oxide in manufacturing industries. The present disclosure also provides a degradation agent for degrading ethylene oxide and a method for biodegrading ethylene oxide.

The present disclosure provides an Alcaligenes faecalis strain capable of degrading ethylene oxide and uses thereof. The deposit number of the strain is CGMCC No. 18435. This strain can be used in pollution treatment, for example, to treat industrial sewage or wastewater containing ethylene oxide, which greatly improves the decontamination ability of ethylene oxide in manufacturing industries. The present disclosure also provides a degradation agent for degrading ethylene oxide and a method for biodegrading ethylene oxide.

The present invention generally relates to bacteriologically pure bacterial cultures of novel strains of plant growth-promoting bacteria, and inoculums comprising the same. The invention is also directed to plant seeds coated with the inoculums, kits comprising the inoculums and methods for stimulating plant growth by applying the biologically pure bacterial culture or the inoculum to a plant, plant seed, or plant growth medium.

A method for producing RNA is provided. Objective RNA is produced by culturing a coryneform bacterium having an expression unit for the objective RNA, which has been modified so that the activity of ribonuclease III is reduced, in a medium, to express the objective RNA and accumulate the objective RNA in cells of the bacterium, and collecting the objective RNA from the cells.

It has been discovered that the desert endophytic bacterium SA187 SA187 can provide resistance or tolerance to abiotic stress conditions to seeds or plants. Compositions containing SA187 can be used to enhance plant development and yield under environmental stress conditions.

A process for producing optically active (R)-3-hydroxybutyrate and (R)-3-hydroxyvalerate mixtures, where the ratio between them is defined by the composition of PHB-co-HV, used as raw material for the production process, formulations containing the mixtures, and uses of the formulations. A use or method of treating a subject having a metabolic disorder, comprising administering optically active mixtures of (R)-3-hydroxybutyrate and (R)-3-hydroxyvalerate, their respective salts or esters derived therefrom, obtained according to the process of the present disclosure at a therapeutically effective amount to treat at least one symptom of the metabolic disorder.

An integrated process for producing polyhydroxyalkanoates and bioethanol including: (a) feeding a part of the lignocellulosic hydrolyzate to a first fermentation device in the presence of one microorganism capable of using sugars with six carbon atoms and organic acids, obtaining a first fermentation broth; (b) subjecting the first broth to separation obtaining an aqueous suspension of cellular biomass having one polyhydroxyalkanoate and an aqueous phase having sugars with five carbon atoms in a quantity greater than or equal to 10 g/L; (c) optionally, feeding a part of the aqueous phase from step (b), to a second fermentation device, obtaining a second fermentation broth (inoculum); (d) feeding at least a part of the aqueous phase from step (b) and, optionally, the second broth and/or at least a part of lignocellulosic hydrolyzate, to a third fermentation device, obtaining a third fermentation broth; and (e) subjecting the third broth to separation obtaining bioethanol.